Loading...

PharmaCyte Biotech, Inc.

PMCB•NASDAQ
Healthcare
Biotechnology
$0.95
$0.005(0.53%)

PharmaCyte Biotech, Inc. (PMCB) Stock Chart & Performance Analysis

Explore PharmaCyte Biotech, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-5.39%
5-Day Change
-8.06%
1-Month Change
-35.96%
3-Month Change
-25.00%
6-Month Change
-34.10%
Year-to-Date (YTD) Change
-30.49%
1-Year Change
-49.56%
3-Year Change
-47.47%
5-Year Change
-97.43%
All-Time (Max) Change
-98.01%

Analyzing PharmaCyte Biotech, Inc. (PMCB) Trends Across Multiple Time Frames

PharmaCyte Biotech, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. PharmaCyte Biotech, Inc. stock shows -5.39% 1-day change, indicating low volatility, while its 5-day change of -8.06% suggests a broader trend. Over a 1-month period, a -35.96% drop could signal a pullback, whereas a 3-month decline of -25.00% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -34.10% and a YTD drop of -30.49% might concern investors, but a 1-year loss of -49.56% and a 3-year drop of -47.47% could indicate resilience. The 5-year surge of -97.43% highlights weak historical growth, while the all-time return of -98.01% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;